Table 2.
Factors associated with hyperglycemia, adult patients in HIV care, Kampala, Uganda, 2020–2021.
| Variable | Crude odds ratios | 95% Confidence interval | Adjusted odds ratios | 95% Confidence interval |
|---|---|---|---|---|
| Previous ART regimen | ||||
| Non-DTG based regimen | 1.0 (ref) | 1.0 (ref) | ||
| DTG based regimen | 34.65 | 12.35–97.23* | 7.01 | 1.96–25.09* |
| Age categories (in years) | ||||
| 18 to 35 | 1.0 (ref) | 1.0 (ref) | ||
| 36 to 45 | 3.25 | 1.61–6.55* | 3.91 | 1.51–10.14* |
| 46 to 55 | 8.01 | 3.98–16.11* | 9.23 | 3.43–24.78* |
| 56 and above | 13.90 | 6.05–31.94* | 12.38 | 3.79–40.50* |
| Current BMI (kg/m2) | ||||
| Underweight (under 18.5) | 1.0 (ref) | 1.0 (ref) | ||
| Normal weight (18.5 to 25) | 0.58 | 0.27–1.25 | 0.24 | 0.77–0.74* |
| Overweight (25 to 30) | 1.03 | 0.48–2.19 | 0.59 | 0.20–1.76 |
| Obese (over 30) | 1.34 | 0.59–3.02 | 0.75 | 0.24–2.39 |
| Hypertension as a comorbidity | ||||
| No hypertension | 1.0 (ref) | 1.0 (ref) | ||
| Has hypertension | 9.13 | 4.76–17.48* | 5.78 | 2.53–13.21* |
| Total duration of ART use | ||||
| Less than 5 years | 1.0 (ref) | 1.0 (ref) | ||
| 5 to 10 years | 1.11 | 0.68–1.82 | 0.56 | 0.25–1.26 |
| 11 and more years | 1.52 | 0.87–2.66 | 0.68 | 0.28–1.66 |
| Current ART regimen | ||||
| Non-DTG based regimen | 1.0 (ref) | 1.0 (ref) | ||
| DTG based regimen | 00.06 | 0.04–0.11 | 0.07 | 0.03–0.16* |
*p-value < 0.05